Zydus Wellness · NSE: ZYDUSWELL · BSE: 531335
Q4 FY21 results · Jan–Mar 2021
Zydus Wellness reported revenue from operations of ₹605.73 crore (up 24.2% from Q4 FY20) and net profit of ₹133.13 crore (up 92.7% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a consolidated basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 605.73 | 487.87 | +24.2% | 381.58 | +58.7% |
| Other income | 1.79 | 1.30 | +37.7% | 2.52 | −29.0% |
| Total income | 607.52 | 489.17 | +24.2% | 384.10 | +58.2% |
| Profit before tax | 132.66 | 61.47 | +115.8% | 1.74 | 76x |
| Net profit for the period | 133.13 | 69.10 | +92.7% | 1.74 | 77x |
| Attributable to shareholders of the company | 134.94 | 71.20 | +89.5% | 1.77 | 76x |
| EPS, basic (₹) | 20.92 | 11.98 | not comparable | 0.27 | 77x |
| Net margin (%) | 22.0 | 14.2 | 0.5 |
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 42.18 | 34.32 | +22.9% | 37.70 | +11.9% |
| Other income | 5.58 | 30.56 | −81.7% | 7.61 | −26.7% |
| Total income | 47.76 | 64.88 | −26.4% | 45.31 | +5.4% |
| Profit before tax | (9.96) | (7.37) | Loss widened | (132.92) | Loss narrowed |
| Net profit for the period | (9.96) | (5.63) | Loss widened | (132.92) | Loss narrowed |
| EPS, basic (₹) | (1.57) | (0.98) | not comparable | (20.89) | Loss narrowed |
| Net margin (%) | -23.6 | -16.4 | -352.6 |
Consolidated
- Filed with BSE
- 11 May 2021, 11:56 IST
- Board meeting
- 10 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 May 2021, 11:56 IST
- Board meeting
- 10 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE